Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Profit Warning/Forecast
Eckert & Ziegler Lowers 2022 Profit Guidance to 27 mm EUR
05-Jul-2022 / 13:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Berlin, 5 July 2022. Due to slow consultation progress and a general worsening of the international business climate the Management Board of Eckert & Ziegler has concluded that the probability of an extraordinary profit from a sale or readjustments of assets, still within calendar year 2022 and in an amount of 14.3 mm EUR, has decreased to less than 50%. On the other hand, a stronger than expected order intake and solid half-year results will raise the 2022 net profit in the recurring business from 24 to 27 mm EUR and hence by 17% compared to 2021. The board therefore in sum revises its 2022 net profit guidance from 38.3 to 27 mm EUR.
The sales forecast for the financial year 2022 published on March 24, 2022 remains unchanged. Here the Executive Board expects an increase to around EUR 200 million. Detailed half year results for 2022 will be published on 11 August 2022.
For enquiries please contact:
|Company:||Eckert & Ziegler Strahlen- und Medizintechnik AG|
|Phone:||+49 30 941084-138|
|Fax:||+49 30 941084-112|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1391015|
|End of Announcement||DGAP News Service|